PetMed Express Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-29.28	-57.29	-6.27	-7.46	5.14	18.72
Depreciation & Amortization	9.25	9.39	7.04	7.06	3.55	2.74
Asset Writedown & Restructuring Costs	-	27.26	1.2	-	-	-
Stock-Based Compensation	0.97	1.37	-6.59	6.87	6.62	4.55
Provision & Write-off of Bad Debts	-0.03	-0.04	0.37	0.32	0.21	0.17
Other Operating Activities	-0.69	-0.69	5.25	0.29	-1.63	-0.85
Change in Accounts Receivable	-0.07	0.45	0.6	-1.74	-0.04	0.51
Change in Inventory	7.77	0.47	12.35	-6.42	13.43	1.97
Change in Accounts Payable	-7.74	-2.66	-13.46	6.1	-2.29	-12.05
Change in Unearned Revenue	-0.48	-1.4	-0.52	-0.39	-	-
Change in Income Taxes	0.1	-0.02	-0.03	0.68	-0.18	0.28
Change in Other Net Operating Assets	-3.61	-5.24	4.78	-0.99	3	2.47
Operating Cash Flow	-23.81	-28.39	4.72	4.32	27.8	18.5
Operating Cash Flow Growth	-	-	9.29%	-84.47%	50.30%	-53.84%
Capital Expenditures	-3.96	-4.62	-5.11	-4.51	-5.26	-1.75
Cash Acquisitions	-	-	-	-35.86	-	-
Investment in Securities	-	-	-	-0.3	-5	-
Investing Cash Flow	-3.96	-4.62	-5.11	-40.67	-10.26	-1.75
Repurchase of Common Stock	-0.25	-0.28	-	-	-	-
Common Dividends Paid	-0.02	-0.02	-0.18	-12.44	-24.54	-24.38
Financing Cash Flow	-0.27	-0.3	-0.18	-12.44	-24.54	-24.38
Net Cash Flow	-28.05	-33.31	-0.58	-48.79	-6.99	-7.64
Free Cash Flow	-27.77	-33.01	-0.4	-0.19	22.54	16.75
Free Cash Flow Growth	-	-	-	-	34.62%	-55.51%
Free Cash Flow Margin	-16.45%	-18.44%	-0.17%	-0.07%	9.11%	6.15%
Free Cash Flow Per Share	-1.31	-1.58	-0.02	-0.01	1.11	0.82
Levered Free Cash Flow	-15.5	-20.37	-7.15	7.56	24.06	33.88
Unlevered Free Cash Flow	-15.41	-20.37	-7.15	7.56	24.06	34.58
Cash Income Tax Paid	0.05	0.05	0.53	0.13	4.31	6.09
Change in Working Capital	-4.04	-8.39	3.72	-2.76	13.92	-6.82

SEC Filings: 10-K · 10-Q